Hundreds attend ‘Walk MS: Longmeadow' to raise funds and awareness
Nearly 400 people showed that people living with Multiple Sclerosis (MS) are not alone. The National Multiple Sclerosis Society's 'Walk MS: Longmeadow' raises awareness and funds to find a cure for the disease.
Fight at Amherst Regional Middle School prompts shelter-in-place, ongoing investigation
About one million people live with MS in the United States. It's unpredictable, and often disabling, but there are resources through the National MS Society, like Walk MS, that help people affected live their best lives. One walker shared why she chose to participate.
'I'm walking because I was recently diagnosed with MS, and I figured this would be a great way to feel supported by the community,' said Degenais Romero of Holyoke.
Romero's relatives also weighed in on their impact.
'It means a lot because it shows how you're supportive, and how everyone's come together,' said Fabian Morales of West Springfield. 'It's a community thing.'
Another attendee was diagnosed nearly 12 years ago, and she said having her village by her side makes all the difference.
'It's a daily fight, and I'm just so happy and blessed to have everybody during this journey,' said Marlaina Ray of Wilbraham.
Organizers said they expect walkers to raise nearly $70,000 for the National MS Society throughout Saturday's event. They were seen waving paddles showing their connection to the disease, whether they're living with MS or supporting a loved one.
Sidewalks were full of orange, the color for MS Awareness, with each step towards the finish line and one step closer to finding a cure.
WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on WWLP.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
a day ago
- Fox News
Specific symptoms could warn of MS more than a decade before diagnosis, study finds
People with multiple sclerosis (MS) may show warning signs long before classic symptoms appear — and mental health concerns could be among the first red flags, according to new research. A University of British Columbia (UBC) study, published last week in JAMA Network Open, examined the medical records of 2,038 patients with the autoimmune disease and compared them to 10,182 patients without it. The researchers found that future MS patients had elevated rates of mental health-related issues, psychiatrist and general practice visits, and complaints of vague symptoms such as fatigue and pain — all as early as 15 years before the onset of clear symptoms. "These findings suggest that MS may begin much earlier than previously recognized, with mental health–related issues as early indicators," the researchers wrote. MS, which attacks the protective myelin coating around nerve cells in the brain and spinal cord, affects about one million adults in the U.S., according to Cleveland Clinic. While there is no known cause or cure, treatment can help manage symptoms and slow the progression of the disease, which can cause muscle weakness, vision changes, numbness and memory issues. Previous research has shown that in the five to 10 years leading up to an MS diagnosis, people typically seek medical attention more frequently for headaches, fatigue, sleep disorders, pain, gastrointestinal issues and psychiatric concerns, the researchers wrote. The UBC study, however, tracked physician visits in the 25 years leading up to the onset of symptoms in MS patients in British Columbia. They found a steady uptick in general practice visits starting 15 years out, followed by more frequent trips to psychiatrists beginning 12 years before symptoms. Neurology and ophthalmology visits increased eight to nine years prior, likely due to blurred vision or eye pain, two common early symptoms of MS. Three to five years before onset, emergency room and radiology visits rose sharply. Across nearly every specialty, physician visits peaked in the year before symptoms began. Psychiatrist consultations, in particular, skyrocketed 159% before MS onset, and mental health visits increased 76%, according to the research. The increase in psychiatric visits may correlate to the earliest stages of MS-related immune dysregulation, as higher levels of certain inflammation-related chemicals and problems with the blood-brain barrier can affect mood, the researchers noted. While most people who experience mental health issues, fatigue and headaches do not develop MS, the researchers said that recognizing and characterizing the "prodromal phase" — the early period marked by subtle symptoms — could speed up diagnosis and improve outcomes. "Mental health and psychiatric-related issues may be among the earliest features of the prodromal phase of MS, preceding nervous system-related symptoms and neurologist visits by several years," senior author Dr. Helen Tremlett, professor of neurology at UBC, told Fox News Digital. "This suggests that in the future, there may be an opportunity to recognize and manage MS early, maximizing mental health and brain reserve," she said. The findings also open "new avenues for research into early biomarkers, lifestyle factors and other potential triggers that may be at play during this previously overlooked phase of the disease," the researcher added. Monitoring for early warning signs could also potentially help to detect other brain diseases, like Alzheimer's or ALS, and ensure early intervention, Tremlett noted. For more Health articles, visit Between 2016 and 2021, MS cases increased globally from about 2.2 million to as many as 2.9 million, according to research published in July in the journal Frontiers in Neurology. The disease has gained public attention in recent years as celebrities like Selma Blair, Christina Applegate and Montel Williams have shared their experiences of living with MS.
Yahoo
2 days ago
- Yahoo
Skittles, M&M's more candy options free of synthetic dyes coming in 2026
Starting next year, Skittles, M&M's, Starburst and Extra Gum will be available free of artificial colors to consumers nationwide. Mars Wrigley North America announced last month that products across four categories of its popular treats -- gum, fruity confections and chocolate candy -- will be made "without Food, Drug & Cosmetic (FD&C) colors" starting in 2026. The first brands to be available without without FD&C colors will include M&M's Chocolate, Skittles Original, Extra Gum Spearmint and Starburst Original fruit chews, the company said. Kraft Heinz, General Mills to remove artificial dyes from food products over next 2 years News of the candy maker's move away from synthetic color additives was first announced on July 24, as reported by Bloomberg. "Mars Wrigley North America has been on an innovation journey over the past few years, dedicated to bringing products that provide consumers delicious choices when they treat," the company said in a press release. "In the United States, we are engaged closely with regulators and aware of the increased dialogue and activity regarding colors. All our products meet the high standards and applicable regulations set by food safety authorities around the world, including the FDA." Anton Vincent, president of Mars Wrigley North America, added that the company's approach "is always consumer-focused and science-led." Mars Wrigley said its experts "are exploring alternatives that satisfy scientific safety criteria, technical requirements and consumer preferences." Once the company has identified a "fully effective, scalable solution," it will share updates on timing and specific product commitments, it said. The move makes Mars Wrigley an early entrant to a growing list of major consumer product goods companies offering a choice of naturally colored products. The change comes amid a push from Health and Human Services Secretary Robert F. Kennedy Jr. to crack down on synthetic food additives as part of his initiative to "Make America Healthy Again." Among those efforts are proposals to phase out artificial food dyes in favor of natural alternatives. In June, Kraft Heinz and General Mills announced plans to remove artificial food dyes from some products within the next two years. Several other large food manufacturers -- including PepsiCo, ConAgra, The Hershey Company, McCormick & Co., J.M. Smucker, Nestlé USA and more -- have announced similar plans in recent months. As of May, the U.S. Food and Drug Administration has approved three additional color additives from natural sources that are in line with the Department of Health and Human Services' goals, which can be used in a wide range of products from gum to breakfast cereal. "For too long, our food system has relied on synthetic, petroleum-based dyes that offer no nutritional value and pose unnecessary health risks. We're removing these dyes and approving safe, natural alternatives -- to protect families and support healthier choices," Kennedy said in a statement at the time. Multiple states have also passed legislation to eliminate food dyes from school lunch programs. Solve the daily Crossword
WebMD
3 days ago
- WebMD
The Push to Diagnose MS Years Before Symptoms Start
Aug. 13, 2025 – What if a blood test could flag multiple sclerosis years before symptoms start? Amid recent breakthroughs in diagnosis and treatment – like advanced MRI techniques and powerful B-cell depletion therapies – scientists say the next frontier in MS care could be prevention. They believe they're on the path toward being able to identify the disease before full symptoms appear, during what's known as the "prodromal" phase. This could give doctors a chance to intervene in the teenage or early adulthood years, potentially preventing a condition that can lead to serious disability or neurological decline. Although it would be many years before such a test becomes available, scientists are laying the groundwork now. Canadian researchers recently analyzed health care visit patterns for more than 10,000 people over 25 years and found that those who eventually developed MS had a clear pattern of doctor visits that differs from those of the general population. Among the findings: A dozen years before their MS diagnosis, patients visited psychiatrists at more than double the rate, compared with people of the same age, gender, and geographic region who did not go on to be diagnosed with MS. What that means, said senior author Helen Tremlett, PhD, is that "people were already changing" during their early to mid-20s, since the average age of the start of MS in the study was 37. A Pattern Stretching Back 15 Years The pattern of health care visits revealed in the study aligns with existing knowledge about early MS symptoms, which include the kind of nondescript health issues – like pain, fatigue, headache, dizziness, anxiety, and depression – that can be challenging for doctors to diagnose. Particularly striking was just how many years before MS onset the pattern of doctor's visits started: 15 years: A decade-and-a-half before clear symptoms developed, people who would eventually develop MS had a 19% higher rate of visits to a general practice doctor, and they were more likely to have doctor visits for "ill-defined symptoms" like fatigue or pain. 12 to 14 years: Mental health visits were markedly higher at 14 years before diagnosis, with a rise in psychiatric visits starting at 12 years and escalating after that. 8 to 9 years: Eye pain and blurry vision are common MS symptoms, and people eventually diagnosed were more likely to seek neurology and ophthalmology care starting eight to nine years earlier. 3 to 5 years: Emergency room visits and radiology visits for medical imaging were higher than those of the general population starting around three to five years before diagnosis. 1 year: The year before an MS diagnosis, doctor visits across specialties peaked. Tremlett, a professor at the University of British Columbia in Vancouver, Canada, cautioned that MS is still uncommon, affecting about 1 million people in the U.S. "The vast majority of people who visit a doctor for the issues we identified do not develop MS and will not develop MS," she said. "No one should feel alarmed or concerned by our findings." Indeed, extra doctor visits for fatigue or pain are not reasons to get an MRI (magnetic resonance imaging) scan to check for MS-related brain lesions, and it's certainly not feasible to test everyone who frequently sees a psychiatrist for depression or anxiety. "We cannot use any of these findings – because they're too general – to accurately identify someone who goes on to develop MS. But I think it's really inspiring to think about: What else do we need? Where do we go to next?" Tremlett said, suggesting that perhaps one day, a person's age, gender, family history, and health care visit pattern could help identify whether they're at high risk. "But here's the key point," she added. "You need to include something more specific." What's really needed, she said, is a blood test. And Yale School of Medicine researchers in New Haven, Connecticut, are working on just such a test. Why a Blood Test for MS Is Not a Far-Fetched Idea Yale professor David Hafler, MD, has studied MS for nearly 50 years. His pivotal research, spanning five decades, identified MS as an autoimmune and genetic disease. A team at his lab is now studying people with a strong family history of MS – an effort that has tallied some 250 genetic variations that heighten risk – with the aim of developing a blood test. The key, Hafler said, is to monitor those who haven't yet had the Epstein-Barr virus (EBV) – an infection that usually doesn't have symptoms and spreads through saliva and body fluids; it infects about 90% of people by age 25. A groundbreaking 2022 study linked the virus to MS. Hafler suspects that in some people, EBV leads to breaking of "tolerance" – that is, it disrupts the immune system's ability to tolerate its own cells. This leads the body's autoreactive T cells to attack healthy cells. Tremlett's study fits the working model many scientists are using of a prodromal phase of MS, Hafler said. "What's happening is the disease is percolating," Hafler said. "I think there is a first stage before the T cells go into the brain, which is what leads to MS." He and his colleagues are watching for changes in blood samples of people being studied after EBV is first detected. The idea: "If someone starts to develop autoreactive T cells, for example, after an EBV infection, I would treat them with B-cell depletion," Hafler said, noting that much more research would be needed before taking that step. Even if a blood test were to be developed, it could raise ethical challenges. Some people have MS that isn't severe, or they have brain lesions identified on an MRI ordered for a different reason and they never go on to develop symptoms. In these scenarios, B-cell depletion treatment might not be worth the potential side effects, like a weakened immune system. Also on the horizon is genetic testing for MS. While not yet available outside of research trials, it's getting more accurate, Hafler said. Alongside those known 250 genetic variants, scientists are examining risk among people whose parents (one or both) have MS. "We haven't validated this yet, and it's not a test you can order," he said, "but the statistics tell us that if you're in the top 10 percentile [of carrying risk-associated genetic variants], you probably have a 1 in 10 chance of developing MS." With the latest research confirming the condition's long prodromal period, "the next step should be identifying patients at risk, and then to monitor them in the moment they show signs of developing MS biomarkers," Hafler said. What to Do if You're Worried About MS It's unlikely that someone with the health care visit patterns revealed in the recent study would be at risk of multiple sclerosis, said MS specialist Brittani Conway, MD, of the University of Minnesota. That said, she also encourages people to advocate for themselves if they think they are having early warning signs. "Trust your intuition," she said. "A lot of patients with MS do actually come to me with a bit of PTSD from their experience of being shuffled around the health care system." Perhaps, for someone who has a first-degree relative with MS, such a pattern or a sudden change could be worth a discussion with your doctor, Hafler said. Conway's advice is to "maintain that determination that there may be something off, even if it's not showing up right away." Also, remember that lifestyle changes – like eating healthy, exercising, and quitting smoking – are all key treatments for MS and for mood disorders, alike. "Focus on what is in your control," Conway said. "Focusing on lifestyle will be very helpful, and it's something that is within the power of the patient even before their diagnosis."
